ChemoCentryx Announces Results of FDA Advisory Committee Meeting on Avacopan in ANCA-Associated Vasculitis
Go back to ChemoCentryx Announces Results of FDA Advisory Committee Meeting on Avacopan in ANCA-Associated Vasculitis| CHEMOCENTRYX (NASDAQ: CCXI) | Delayed: 13.60 +0.20 (1.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.40 | 52 Week High | $8.30 | |||
| Open | $13.36 | 52 Week Low | $1.92 | |||
| Day High | $14.16 | P/E | N/A | |||
| Day Low | $13.10 | EPS | $-1.00 | |||
| Volume | 1,744,342 | |||||
